Filter
101
Text search:
praziquantel
treatment
Featured
Recommendations
17
New Publications
27
Language
Document type
No document type
42
Studies & Reports
28
Guidelines
13
Strategic & Response Plan
7
Manuals
6
Fact sheets
4
Infographics
1
Countries / Regions
Global
10
Uganda
5
Ethiopia
4
Senegal
3
Zimbabwe
3
Tanzania
3
Sierra Leone
2
Liberia
2
Nigeria
2
Philippines
2
South Africa
2
Namibia
2
Botswana
2
West and Central Africa
2
Latin America and the Carribbean
2
Burkina Faso
1
India
1
Somalia
1
Chad
1
Kenya
1
Rwanda
1
Malawi
1
Mozambique
1
Sudan
1
Ukraine
1
Angola
1
Madagascar
1
Myanmar / Burma
1
East and Southern Africa
1
Southern Africa
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
34
Clinical Guidelines
25
Public Health
8
Women & Child Health
5
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
NTDs
30
Pharmacy
13
AMR
4
Planetary Health
3
Conflict
2
Mental Health
1
COVID-19
1
Caregiver
1
Health Financing Toolbox
1
NCDs
1
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered
...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial.
...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment
...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
Situation Analaysis and Needs Assessment
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
Volume 1 covers emergency triage assessment and treatment, and acute care for a severely ill or acutely injured patient for approximately the first 24 hours of care. It describes the clinical procedures commonly used in emergency and acute care, and
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
